We are live on ! Find out more
MPU

MVM Partners (UK) Portfolio holdings

AUM $149M
1-Year Est. Return 6.81%
This Fund
S&P 500
This Quarter Est. Return
-8.81%
1 Year Est. Return
+6.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$281M
AUM Growth
Cap. Flow
+$317M
Cap. Flow %
113.13%
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
FNA
Paragon 28, Inc.
FNA
+$280M
2
OPTN
OptiNose
OPTN
+$27.9M
3
MDXH icon
MDxHealth
MDXH
+$8.98M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNA
1
DELISTED
Paragon 28, Inc.
FNA
$252M 89.8%
+14,543,990
New +$280M
OPTN
2
DELISTED
OptiNose
OPTN
$20M 7.13%
+833,333
New +$27.9M
MDXH icon
3
MDxHealth
MDXH
$22.4M
$8.6M 3.07%
+916,666
New +$8.98M

Similar funds

MVM Partners (UK)'s Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for MVM Partners (UK), which disclosed 3 positions worth $281M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Paragon 28, Inc.: 14,543,990 shares worth $252M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • MVM Partners (UK)'s largest Q4 2021 buy was Paragon 28, Inc.: 14,543,990 shares worth $252M.
  • MVM Partners (UK)'s ten largest holdings make up 100% of its $281M portfolio in Q4 2021.
  • MVM Partners (UK) disclosed 3 positions in Q4 2021, its first 13F filing on record.

Based on MVM Partners (UK)'s 13F filing for Q4 2021, filed 25 Oct 2024.